Binding of suprofen to human serum albumin. Role of the suprofen carboxyl group.
The binding of suprofen (SP), a non-steroidal anti-inflammatory drug of the arylpropionic acid class, and its methyl ester derivative (SPM) to human serum albumin (HSA) was studied by dialysis and spectroscopic techniques. In spite of the remarkable differences in the physicochemical properties of SP and SPM, the binding of each molecule to HSA was quantitatively very similar. Thermodynamic analysis suggests that the interaction of SP with HSA may be caused by electrostatic as well as hydrophobic forces, whereas the interactions with SPM may be explained by hydrophobic and van der Waals forces. Similarities in the difference UV absorption spectra between ligand-detergent micelle and -HSA systems indicate that the SP and SPM molecules are inserted into a hydrophobic crevice on HSA. The same studies suggest that the carboxyl group of SP interacts with a cationic sub-site which is closely associated with the SP binding site. Proton relaxation rate measurements indicate that the thiophen ring and propanoate portion of the SP molecule is the major binding site for HSA. The locations of SP and SPM binding sites were identified by using fluorescence probes which bind to a known site on HSA. The displacement data implied that SP primarily binds to Site II, while the high affinity site of SPM as well as low affinity site of SP are at the warfarin binding site in the Site I area. From binding data with chemically modified HSA derivatives, it is likely that highly reactive tyrosine (Tyr) and lysine (Lys) residues, which may be Tyr-411 and Lys-195, are specifically involved in SP binding. In contrast, these two residues are clearly separated from the SPM binding site. The binding of SP and SPM is independent of conformational changes on HSA that accompany N-B transition. There is evidence that the carboxyl group may play a crucial role in the high affinity binding processes of SP to HSA.
Maruyama
T
T
Faculty of Pharmaceutical Sciences, Kumamoto University, Japan.
Lin
C C
CC
Yamasaki
K
K
Miyoshi
T
T
Imai
T
T
Yamasaki
M
M
Otagiri
M
M
D015077:2-Hydroxy-5-nitrobenzyl Bromide / Q000378:metabolism; D001665:Binding Sites; D005454:Fluorescence Polarization; D006801:Humans; D006863:Hydrogen-Ion Concentration; D009682:Magnetic Resonance Spectroscopy; D012709:Serum Albumin / Q000378:metabolism*; D013056:Spectrophotometry, Ultraviolet; D013387:Succinic Anhydrides / Q000378:metabolism; D013496:Suprofen / Q000737:chemistry / Q000378:metabolism*; D013774:Tetranitromethane / Q000378:metabolism; D013816:Thermodynamics
D012709:Serum Albumin; D013387:Succinic Anhydrides; C031801:succinic anhydride; D015077:2-Hydroxy-5-nitrobenzyl Bromide; D013496:Suprofen; D013774:Tetranitromethane